CA2379498C - Plant gene expression, controlled by constitutive plant v-atpase promoters - Google Patents

Abstract

To express selection and resistance genes, it is desirable to have plant constitutive promoters available which have strong, homogenous constitutive activity, if possible in all plant tissues or cell types and which, in addition, become more active or cannot be repressed in conditions of stress.
The invention concerns DNA syntheses which contain a plant V-ATPase promoter which is operatively bound to a heterologous gene. The invention also relates to the use of these syntheses in the form of expression cassettes, recombinant vectors and in transgenic plants, plant cells or protoplasts. The invention relates, in particular, to the promoter of the Beta vulgaris V-ATPase subunit c isoform 2.

Description

PLANT GENE EXPRESSION, CONTROLLED BY CONSTITUTIVE
PLANT V-ATPASE PROMOTERS

Plant gene expression under the control of constitutive plant V-ATPase promoters.

The invention relates to DNA constructs which encompass a plant V-ATPase promoter which is operatively linked to a heterologous gene. The invention furthermore relates to the use of these constructs in the form of expression cassettes, recombinant vectors and in transgenic plants, plant cells or protoplasts. In par-ticular, the invention relates to the promoter of Beta vulgaris V-ATPase subunit c isoform 2.
Genetic engineering methods allow foreign genes to be transferred specifically into the genome of a plant.
This process is termed transformation, and the resulting plants are termed transgenic plants. When expressing foreign genes in plants, the choice of the promoter is frequently a critical factor. While it may be desirable to express a gene only as the response to a particular abiotic or biotic stimulus or to localized expression in a specific tissue, other genes should preferably be expressed constitutively, i.e. in the entire plant at all times and in all tissues.

Examples for expression which can be induced by a particular stimulus are the wound induction, which is described, for example, in WO 93/07279 and, for pota-toes, in EP 0 375 091 Al, or chemical induction, which has been described in WO 95/19443 (Ward et al. (1993) Plant Molecular Biology 22, 361-366), such as, for example, the induction with salicylate, which is known from EP 0 337 532 B1, or light induction (Fluhr et al.

(1986) Science 232, 1106-1112 and WO 91/05054), and temperature-dependent induction, also described in EP 0 337 532 B1 and, for tomatoes, in WO 96/12814.

Examples of cell- and tissue-specific expression are seed-, tuber- and fruit-specific expression (see review by Edwards and Coruzzi (1990) Annu. Rev. Genet. 24, 275-303 and US 5,753,475).

Phloem-specific expression (SchmUlling et al. (1989) Plant Cell 1, 665-670), root-nodule-specific expression (DE 3702497) and meristem-specific expression (Ito et al. (1994) Plant Molecular Biology 24, 863-878) are also known.
Promoters which cause constitutive expression of the genes controlled by them can be employed, for example, for selecting transformed plant cells (expression of a selectable marker gene in transgenic plants, generation of antibiotic-resistant plant cells) or for generating herbicide-tolerant, insecticide-tolerant and pathogen-stress-resistant plants, since the products of the genes controlled by them are present in all parts of the plant.
Foreign genes of other agronomic, medicinal or other importance can be expressed in a variety of plants, for example for generating heterologous recombinant proteins and for generating plants which contain mammalian polypeptides. The quantity of the expression pattern over space and time, of endogenous plant genes, can also be advantageously altered with the aid of constitutively active promoters.

The constitutive promoter which is most frequently used in plant genetics is the viral 35S CaMV promoter (Franck et al. (1980) Cell 21, 285-294). This promoter contains different recognition sequences for transcrip-tional effectors which, in their totality, result in constitutive expression of the gene which has been introduced (Benfey et al. (1989) EMBO J. 8, 2195-2202).
Other constitutive promoters of viral origin are, for example, the fig-wort mosaic virus promoter, which has been described in EP 0 426 641, the Australian banana-infecting badnavirus (WO 99/00492) and the sugar cane bacilliform virus promoter described in WO 99/09190.

Plant-intrinsic constitutive promoters are, for example, the maize ALS promoter (WO 96/07746), the rice actinl promoter (McElroy et al., Plant Cell 2, 163-171, 1990, US 5,641,876), the wheat proline-rich protein promoter described in WO 91/13991, the raspberry DRU
promoter (WO 97/27307) and the Medicago sativa H3 histone promoter (WO 97/20058).

To express selection genes and resistance genes, it would be desirable to have available promoters which show a strong, uniform constitutive activity in, if possible, all plant tissues or cell types and which, moreover, show even greater activity, or are not repressed, under stress conditions. Advantageously, these promoters should not be derived from plant patho-gens (as is the 35S CaMV promoter), whose expression might also differ in different plant tissues.
Regulation of the constitutive 35S promoter by stress factors has not been described (frequently, elements of other stress-inducible promoters are coupled to the CaMV 35S promoter); most of the stress-induced pro-moters show a virtually undetectable expression under normal conditions (which is a disadvantage) and are only strongly induced under the respective inducing stress conditions. They are therefore unsuitable for many uses.

WO 94/21793 describes a constitutive promoter which is modulated by environmental conditions. This is a con-stitutive promoter from tobacco which is induced by heat and hormone shock, by wounding, and by biotic induction and infection. WO 94/21793 proposes to use this promoter for selecting crop protection agents or for protecting the plant from stress situations.

As a further example, EP 0 559 603 describes the con-stitutive promoter of cauliflower heat-shock protein hsp80. Parts of this promoter can also lead to consti-tutive expression in heterologous, non-constitutive promoters, for example in the case of inducible pro-moters, promoters which can be regulated by other means or inactivated promoters. EP 0 559 603 furthermore des-cribes that genes which mediate resistance to insects, herbicide resistance genes, antimicrobial genes, anti-fungal genes, antiviral genes and anti-feedant genes can be under the control of this promoter. The hsp80 promoter has a very high constitute activity which, however, is only slightly elevated under stress con-ditions, which is a disadvantage.

The V-type H+-ATPase (V-ATPase) plays a central role in the cells of higher plants since it contributes sub-stantially to establishing the electrochemical H+
gradient on the tonoplast. It accounts for a large pro-portion (7-35%) of the overall tonoplast protein (Klink et al. (1990) Bot. Acta 103, 24-31; Fischer-Schliebs et al. (1997) Biol. Chem. 378, 1131-1139). Moreover, V-ATPase is also found in the membranes of the Golgi vesicles. Thus, it is also relatively strongly expres-sed in cells which do not contain a large central vacuole. Plant V-ATPases are composed of at least 10 different subunits which, in defined stoichiometry, form a hollow enzyme of approx. 500 000 kD. In addition to the vacuole pyrophosphatase (V-PPiase), which is frequently expressed on the same endomembranes, V-ATPase plays a central role in processes such as cell division, cell elongation and metabolite or salt accumulation in the vacuoles.

Studies on the expression control of a plurality of V-ATPase genes in various plants (sugar beet, tobacco, carrot, maize, Mesembryanthem um crystallinum) have demonstrated that at least some V-ATPase genes show a coordinated expression with regard to the transcript quantities (Rausch et al. (1996) J. Plant Physiol. 148:
425-433; Low et al. (1996) Plant Physiol. 110: 259-265;
Low and Rausch (1996) J. Exp. Bot. 47: 1725-1732;
Kirsch et al. (1996) Plant Mol. Biol. 32: 543-547; Lehr et al. (1999) Plant Mol. Biol. 39: 463-475).

Summary of the invention It is an object of the invention to provide a DNA construct with a plant B. vulgaris V-ATPase promoter subunit c isoform 2 [SEQ ID No.1] operatively linked with a heterologous gene.

It is an object of the invention to provide a polynucleotide comprising the sequence of the promoter of B. vulgaris V-ATPase subunit c isoform 2 [SEQ ID
No.1 ].
It is an object of the invention to provide a recombinant vector which comprises a DNA construct of the invention.

It is an object of the invention to provide a microorganism which is transformed with a recombinant vector of the invention.

It is an object of the invention to provide a transgenic plant cell or protoplast whose genome comprises a DNA construct of the invention.

5a It is an object of the invention to provide a method for the controlled expression of a heterologous gene in a plant cell or a protoplast, which comprises transforming the cell or the protoplast with a DNA construct of the invention and subsequently exposing the transformed cell or the protoplast to such a biotic or abiotic stress that the expression of the heterologous gene which has been transformed by means of the DNA construct is controlled.

It is an object of the invention to provide a method for the controlled expression of a heterologous gene in a plant, which comprises regenerating cells or protoplasts transformed with a DNA construct of the invention to give rise to a transgenic plant and subsequently exposing the plant transformed in this way to such a biotic or abiotic stress that the expression of the heterologous gene which has been transformed by means of the DNA construct is controlled.

It is an object of the invention to provide a method for producing a recombinant protein in a plant, which comprises:
transforming a plant cell or a protoplast with a DNA construct of the invention and subsequently exposing the transformed cell or protoplast to such a biotic or abiotic stress that the recombinant protein transformed by means of the DNA construct is expressed.
It is an object of the invention to provide a method of producing a recombinant protein in a plant, which comprises regenerating cells or protoplasts transformed with a DNA construct of the invention to give rise to a transgenic plant and subsequently exposing the resulting transgenic plant to such a biotic or abiotic stress that the recombinant protein transformed by means of the DNA construct is expressed.

5b It is an object of the invention to provide the use of a DNA construct of the invention for producing a recombinant protein in a plant cell or a protoplast.

It is an object of the invention to provide the use of a DNA construct of the invention for producing a recombinant protein in a plant.

It is an object of the invention to provide the use of a DNA construct of the invention for expressing a gene in a plant under biotic or abiotic stress.

It is an object of the invention to provide the use of a plant V-ATPase promoter for expressing a gene in a plant under biotic or abiotic stress.

It is an object of the invention to provide the use of a plant B. vulgaris V-ATPase promoter subunit c isoform 2 [SEQ ID No.1] for expressing a gene in a plant under biotic or abiotic stress.

It is an object of the invention to provide a plant cell or protoplast which is transformed with a DNA construct of the invention and which is resistant to biotic or abiotic stress.

It is an object of the invention to provide a plant cell or protoplast of the invention which is resistant to salt stress.

BRIEF DESCRIPTION OF THE DRAWINGS

Figure 1 is a schematic representation of the construct pBVA-70(16)/GUS and pBVA-70(16)/LUC.
Figure 2 shows the construction of the construct pBVA-70/LUC.

Figure 3 Figure 2 shows the construction of the construct pBVA-16/LUC.

5c Figure 4 shows the construct pBVA/16-2 promoter deletions.
Figure 5 shows the construct pBVA/16-1 promoter deletions.

Figure 6 shows the comparison of the activity of different promoters under control conditions.

Figure 7 shows a Northern Blot analysis of the expression of the C2 isoform in Beta Vulgaris.

Figures 8A and 8B show the comparison of the activities of different deleted promoters under control conditions. The numbers beneath the columns refer to the various deletion fragments shown in Figures 4 and 5.

Figures 9A and 9B show the activities of the V-ATPase promoters after exposure to 125 mM for at least 24 hours in B compared to A (control).

Figure 9C shows a Northern Blot analysis wherein the transcript quantities for the V-ATPase genes A, c, and c2 after exposure to salt are elevated compared with the control treatment.

Figure 10 shows a Northern Blot analysis for detecting the gene expression of V-ATPase and V-PPiase in storage parenchyma cells of sugar beet after mechanical wounding.

Figure 11 shows a Western Blot analysis with a polyclonal antiserum against the K. daigremontiana V-ATPase holoenzyme and shows wound-induced changes in V-ATPase on the tonoplast in the storage parenchyma of the sugar beet, A) after 5d wounding, subunit c protein quantity increases the enriched tonoplast fraction as a function of time, B) in the total microsome fraction, the quantities of the individual subunits remain unchanged.

Figure 12 shows wound-induced changes in the H+-pump activity of the V-ATPase in the microsomal and in the enriched tonoplast fractions, in the presence of M vanadate and 1 mM azide.

Detailed description of the invention It is an object of the present invention to provide novel DNA constructs with plant constitutive promoters which show improved properties over the prior-art plant or viral promoters and which allow a strong, constitu-tive gene expression in all plant organs which is modulated by salt stress and other biotic or abiotic factors. In particular, the DNA constructs are intended to be suitable for expressing selection markers and resistance genes.

We have found that this object is achieved by a DNA
construct in which a plant V-ATPase promoter or its functional equivalent operatively linked to a hetero-logous gene is present. According to the invention, this plant V-ATPase promoter may also be a deleted or hybrid V-ATPase promoter which remains functionally active as promoter.

The plant V-ATPase promoter may be derived from either dicotyledonous or monocotyledonous plants, for example from sugar beet, tobacco, barley, rice, potatoes, sunflowers, soya, tomatoes, Canola, wheat, oilseed 5e rape, sorghum, carrots, maize, Mesembranthemum crystallinum or Arabidopsis thaliana.

The plant V-ATPase promoter is preferably the promoter of the B. vulgaris V-ATPase subunit A [SEQ ID No. 3], B. vulgaris V-ATPase subunit c isoform 1 [SEQ ID No. 2]
or B. vulgaris V-ATPase subunit c isoform 2 [SEQ ID
No. 1].

It is a further object of the invention to provide a novel constitutive plant promoter of the abovementioned type.

We have achieved this object by a polynucleotide encom-passing the sequence of the promoter of B. vulgaris V-ATPase subunit c isoform 2 [SEQ ID No. 1] or a poly-nucleotide encompassing its functional equivalent.

Expedient embodiments of the invention are characteri-zed in the subclaims.

Thus, the DNA construct according to the invention can encompass a second promoter which can be regulated in a different manner than the first promoter, thus allowing a more flexible expression control. Moreover, at least one further pyrimidine stretch can be inserted in the promoter, and this affects promoter activity.

The DNA construct according to the invention is prefer-ably an expression cassette. It is further preferred that the heterologously expressed gene is a selection marker or a resistance-mediating gene. Examples of such heterologous genes are insecticidal toxins (such as, for example, of Bacillus thuringiensis), herbicide resistance genes, antimicrobial genes, antifungal genes, antiviral genes and anti-feedant genes. Other suitable genes are, for example, selectable genes, reporter genes or killer genes. Examples of selectable genes are genes for resistance to antibiotics such as neomycin transferase genes, hygromycin phosphotrans-ferase genes or phosphinothricin acetyltransferase genes or, alternatively herbicide resistance genes such as glufosinate, bromoxynil, sulfonamide or glyphosate resistance genes (for more information, see Glick and Thompson, Methods in Plant Molecular Biology and Biotechnology, CRC Press London, Chapter 6.7, pages 71-119). Examples of reporter genes are genes which code for chloramphenicol acetyltransferase (CAT), P-glucuronidase (GUS), luciferase (LUC), green fluores-cent protein (GFP) or thaumatin. Examples of killer genes are the barnase gene, the TA29 gene or the Diphtheria toxin gene (for more information, see "Transgenic Plants", E. Gaulun and A. Breiman, Imperial College Press, London, 1997).

The invention furthermore provides a recombinant vector with a DNA construct according to the invention. This vector may also be a shuttle vector, which facilitates its handling.

In a further embodiment of the invention, the recombi-nant vector is an expression vector. Also, transformed microorganisms are provided together with the recombi-nant vector, for example a transformed Agrobacterium tumefaciens.

A preferred embodiment of the invention relates to a transgenic plant cell or a protoplast whose genome encompasses a DNA construct according to the invention.
This transgenic plant cell or protoplast can be derived both from a monocotyledenous and from a dicotyledenous plant. Preferred cells or protoplasts are those from sugar beet, tobacco, barley, rice, potatoes, sun-flowers, soya, tomatoes, Canola, wheat, oilseed rape, sorghum, carrots, maize, Mesembranthemum crystallinum or Arabidopsis thaliana.

Especially preferred is a transgenic plant according to the invention whose genome encompasses a DNA construct according to the invention. The transgenic plant can be both a monocotyledenous and a dicotyledenous plant.
Especially preferred are plants such as sugar beet, tobacco, barley, rice, potatoes, sunflowers, soya, tomatoes, Canola, wheat, oilseed rape, sorghum, carrots, maize, Mesembranthemum crystallinum or Arabidopsis thaliana.

The invention furthermore provides a process for the controlled expression of a heterologous gene in a plant cell or a protoplast which allows a strong, constitu-tive gene expression in all plant organs which is modulated by salt stress and other biotic or abiotic factors. The process according to the invention com-prises firstly transforming the cell or the protoplast with a DNA construct according to the invention, for example an expression cassette, and subsequently exposing the transformed cell or the protoplast to such a biotic or abiotic stress that the expression of the heterologous gene transformed by means of the DNA
construct is controlled efficiently. This stress may occur in the form of salt stress, for example by NaCl or KC1, phosphate deficiency, nitrogen deficiency, sucrose deficiency, wounding, infection, temperature, drought, herbicides or mechanical stress. According to the invention, the plant cells or protoplasts used for the process can be obtained from a monocotyledenous or dicotyledenous plant, preferably from sugar beet, tobacco, barley, rice, potatoes, sunflowers, soya, tomatoes, Canola, wheat, oilseed rape, sorghum, carrots, maize, Mesembranthemum crystallinum or Arabidopsis thaliana.

The method according to the invention may also be used for the controlled expression of a heterologous gene in a plant. This method comprises regenerating cells or protoplasts transformed with a DNA construct according to the invention to give rise to a transgenic plant and subsequently exposing the transgenic plant to such a biotic or abiotic stress that the expression of the heterologous gene transformed by means of the DNA
construct is controlled efficiently. This stress may occur in the form of salt stress, for example by NaCl or KC1, phosphate deficiency, nitrogen deficiency, sucrose deficiency, wounding, infection, temperature, drought, herbicides or mechanical stress. The transgenic plants used for the process can be obtained from a monocotyledenous or dicotyledenous plant, preferably from sugar beet, tobacco, barley, rice, potatoes, sunflowers, soya, tomatoes, Canola, wheat, oilseed rape, sorghum, carrots, maize, Mesembranthemum crystallinum or Arabidopsis thaliana.
Furthermore, the invention provides a method which allows the efficient production of a recombinant protein in a plant cell or a protoplast. To do this, the cell or the protoplast is transformed with a DNA
construct according to the invention, and the transformed cell or the protoplast transformed thus subsequently exposed to such a biotic or abiotic stress that the recombinant protein transformed by means of the DNA construct. is expressed. This stress may occur in the form of salt stress, for example by NaCl or KC1, phosphate deficiency, nitrogen deficiency, sucrose deficiency, wounding, infection, temperature, drought, herbicides or mechanical stress. The protein produced in this way can subsequently be isolated from the plant cell or the protoplast by methods known to those skilled in the art. The plant cells or protoplasts used for the process may be derived from a monocotyledenous or dicotyledenous plant. Especially preferred plant cells or protoplasts are those from sugar beet, tobacco, barley, rice, potatoes, sunflowers, soya, tomatoes, Canola, wheat, oilseed rape, sorghum, carrots, maize, Mesembranthemum crystallinum or Arabidopsis thaliana.

Moreover, the invention provides a method which allows the efficient production of a recombinant protein in a plant. The method comprises regenerating cells or protoplasts which have been transformed with a DNA-construct according to the invention to give rise to a transgenic plant and subsequently exposing the resulting transgenic plant to such a biotic or abiotic stress that the recombinant protein transformed by means of the DNA construct is expressed. This stress may occur in the form of salt stress, for example by NaCl or KC1, phosphate deficiency, nitrogen deficiency, sucrose deficiency, wounding, infection, temperature, drought, herbicides or mechanical stress. The protein produced in this way can subsequently be isolated from the plant. The plants used for the process may be monocotyledenous or dicotyledenous plants. Especially preferred are plants such as sugar beet, tobacco, barley, rice, potatoes, sunflowers, soya, tomatoes, Canola, wheat, oilseed rape, sorghum, carrots, maize, Mesembranthemum crystallinum or Arabidopsis thaliana.
Moreover, the present invention extends to the use of a DNA construct according to the invention for producing a recombinant. protein in a plant, plant cell or a protoplast. The invention also extends to recombinant proteins produced by one of the methods according to the invention.

However, the DNA construct according to the invention may also be used for expressing a gene in a plant under biotic or abiotic stress. Moreover, the plant V-ATPase promoter according to the invention can be used for expressing a gene in a plant under biotic or abiotic stress. This promoter may also be used in the form of a deleted or hybrid V-ATPase promoter. Plant V-ATPase promoters according to the invention from dicoty-ledenous or monocotyledenous plants may be used. The use of plant V-ATPase promoters from sugar beet, tobacco, barley, rice, potatoes, sunflowers, soya, tomatoes, Canola, wheat, oilseed rape, sorghum, carrots, maize, Mesembranthemum crystallinum or Arabidopsis thaliana is preferred. Especially preferred are the V-ATPase promoters of the Beta vulgaris V-ATPase subunit A [SEQ ID No. 3], B. vulgaris V-ATPase subunit c isoform 1 [SEQ ID No. 2] or B. vulgaris V-ATPase subunit c isoform 2 [SEQ ID No. 1]. Moreover, at least one additional pyrimidine stretch may be inserted into the promoter used.
The invention furthermore relates to a plant cell or protoplast which has been transformed with a DNA
construct according to the invention and which is resistant to biotic or abiotic stress. This stress may occur in the form of salt stress, for example by NaCl or KC1, phosphate deficiency, nitrogen deficiency, sucrose deficiency, wounding, infection, temperature, drought, herbicides or mechanical stress. A transformed salt-stress-resistant plant cell or protoplast is preferred.

The invention furthermore extends to a plant trans-formed with a DNA construct according to the invention which is resistant to biotic or abiotic stress, prefer-ably a transformed salt-stress-resistant plant.

A total of three different V-ATPase genes were isolated from a genomic library of Beta vulgaris. The cDNA
clones and the genomic clones for the subunits A and cl, which correspond to the peripheral V1 complex and the membrane-integrated VO complex, have already been described (Lehr et al., Plant Molecular Biology 39, 463-475 (1999, GenBank/EMBL-Datenbank: X98767, X98851, Y11038, Y11037).
RNA blot analyses with gene-specific cDNA probes show expression of the cloned subunits A and cl and of the isoforms c2, which have been cloned for the purposes of the present invention, in roots, leaves and in a sugar beet suspension culture.

Surprisingly, it has emerged that all three promoters show a very high activity, which, as a rule, exceeds that of the 35S CaMV promoter.

It seems that polypyrmidine sequences which are present in the promoters play an important role in this con-text. The isoforms A and cl each have two such sequence stretches while the isoform c2 only has one such sequence stretch.

It has now surprisingly been found within the context of the present invention that the plant V-ATPase promoters are outstandingly suitable for constructing DNA constructs which can preferably be used as plant expression cassettes.

These expression cassettes can be used for causing, in the plant, an expression of heterologous proteins which is governed by environmental effects. The invention thus allows the plant or the plant cell to be equipped with one or even more heterologous genes which are induced in the plant additionally to its constitutive expression "when required" by the plant (when the environment changes).

Luciferase reporter gene studies on the promoter V-ATPase A and cl from sugar beet and the 35S promoter were carried out on sugar beet cell cultures under salt stress (Lehr et al., Plant Mol. Biol. 39, 463-475, 1999). An induction of the promoter activity was detec-ted for the isoforms A and cl. The 35S CaMV promoter activity, which was studied for comparison reasons, is not induced by salt and indeed repressed. Within the invention, a surprising induction of all three promoters by 100 mM NaCl or 100 mM KC1 was found, even though all three promoters differ with regard to their DNA sequence.
Surprisingly, it has furthermore been found that the promoters according to the invention show no reduced promoter activity in the case of phosphate defi-ciency/nutrient deficiency, which is in contrast to the 35S CaMV promoter. Thus, the constitutive expression remains ideally stable.

In contrast, the promoter activity is induced by wounding, while the 35S CaMV promoter is not induced under comparable conditions. Also, it has been found that the promoter activity is affected by sucrose deficiency; it reduces the activity of cl, but not the activity of the 35S CaMV promoter.
It has also been found that the promoter activities are affected by abiotic factors such as high (30-35 C) or low (2-5 C) temperatures.

In addition, it has been found that various deletions can be introduced into this promoter, which leads to this promoter showing either a) an increased activity, b) an essentially identical activity to that of the native promoter, c) a reduced activity, d) a higher inducibility under stress conditions than the native promoter, or e) a lower inducibility under stress conditions than the native promoter.

"Operatively linked" means such an arrangement that the normal function of the components can be carried out.
An encoding sequence which is "operatively linked" with a control sequence therefore indicates a configuration in which the encoding sequence can be expressed under the control of the sequences.
The term "control sequences" describes DNA sequences which are required for expressing an operatively linked encoding sequence in a host organism. The control sequences which are suitable for, for example, prokaryotes, encompass a promoter, an optional operator sequence, a ribosome binding site and, possibly, other sequences which are not well understood as yet.
Eukaryotic cells are known for containing promoters, polyadenylation signals and enhancers.

The term "gene" refers to a DNA sequence which encodes a bioactive polypeptide which can be isolated, or a precursor. The polypeptide can be encoded by a full-length sequence or by any part of the encoding sequence as long as the enzymatic activity is retained.

An aspect of the invention is therefore a DNA construct with a plant V-ATPase promoter or its functional equivalent, operatively linked with a heterologous gene. It is known that minor changes may be present in the promoter sequence, for example caused by the degeneration of the genetic code, without substantially affecting its activity. The present invention therefore also relates to "functional equivalents" of the plant V-ATPase promoters which are operatively linked with a heterologous gene.

The term "functional equivalents" characterizes all DNA
sequences which are complementary to a DNA sequence, which hybridize with the reference sequence under stringent conditions and which show an activity which is similar to that of a plant V-ATPase promoter.

"Stringent hybridization conditions" are to be under-stood as meaning those conditions under which hybridi-zation takes place, and remains stable, at 60 C in 2.5 x SSC buffer followed by repeated washing steps at 37 C at a lower buffer concentration.
"Heterologous genes" are DNA sequences which encode peptides or proteins which are other than the plant V-ATPase subunits A, ci or c2.

A "deleted or hybrid V-ATPase promoter" is any V-ATPase promoter which has a deletion or whose make-up is altered and which still has promoter activity.

The invention will be described in greater detail hereinbelow in connection with the drawings.

I. Method of obtaining the genomic library of Beta vulgaris L.

Generation of a genomic library A genomic library was established with leaf material of Beta vulgaris L. type 3A39111 in the "Lambda Fix II/
Xho I partial fill-in" vector by Stratagene.

The use of the "Lambda Fix II/Xho I partial fill-in kit" allows genomic DNA fragments to be cloned effi-ciently without the laborious size fractionation via an agarose gel. To this end, the genomic DNA is subjected to a partial digest with the restriction endonuclease Sau3 AI, and the free ends are filled up with Klenow polymerase, incorporating dGTP and dATP. The resulting 3'-AG-5' overhangs prevent autoligation of the genomic DNA fragments. Also, the 3'-CT-5' overhangs of the vector (vector digested with Xho I, partially filled-in ends with dCTP, dTTP) prevent a religation of the central vector fragments ("stuffer element"). Amplifi-cation of wild-type Lambda Fix II phages (containing the stuffer element) is also prevented by using the P2 lysogenic E. coli strain XLI-Blue MRA(P2).
Thus, the method used allows recombinant genomic clones in the desired size range to be obtained in very high yield.
Partial digest of genomic DNA
The optimal enzyme concentration for obtaining frag-ments in the required size range of 15-23 kb is determined by a test digest. To do this, individual reactions together with a DNA marker are fractionated in a low-concentration agarose gel, and the average fragment sizes are determined. Since the electro-phoretic fractionation causes a delay in the migration behavior in particular in the high-molecular DNA range, fragment size cannot be determined directly via the maximum fluorescence intensity. Rather, Seed et al.
(1982) maintain that fragment size is overestimated by a factor of 2. To obtain fragments in the desired size range, only half of the optimal enzyme concentration determined via gel electrophoresis is therefore employed for the preparative digest.

Test digest For the test digest, the restriction enzyme Sau3A I
(10 U/ l, Promega) is diluted in restriction buffer [1 x buffer B (Promega) supplemented with 0.1 mg/ml acetylated BSA (Sigma)] to 'concentrations of 0.1 U/[ul, 0.05 U/[l; 0.025 U/ l, 0.01 U/ l], and the enzyme solutions are stored on ice. 25 g of CsC12-purified genomic DNA dissolved in TE buffer are resuspended in a total volume of 1.125 ml of restriction buffer (see above) and stored in reaction vessels on ice in 225 l-aliquots. The DNA solutions (in each case 5 pg of DNA) are preheated for approximately 20 minutes in a waterbath at 37 C, and the individual reactions are started by adding 25 ill of the restriction enzyme solu-tion. 25 l of pure buffer solution are added to a control sample. The digest is carried out for 2 minutes at 37 C and is stopped by adding 10 l-portions of 0.5 M Nat EDTA. The DNA is then precipitated by adding 1 volume of isopropanol and 0.1 volume of 3 M sodium acetate (pH 7), washed with 70% ethanol, dried, and then resuspended in 10 l-portions of TE buffer.
The reaction batches are separated by electrophoresis overnight in an 0.5% TAE gel (track length 19 cm) stained with ethidium bromide, overnight at 2 V/cm and RT. The size marker used in the present experiment was lambda DNA digested with Hind III, and the 1-kb-DNA
ladder (Gibco, BRL).

Preparative digest The conditions for the preparative digest correspond essentially to those of the test batch. To standardize the reactions, DNA concentration, overall volume of the reaction batch, and time, remain unchanged. The enzyme concentration results from the test digest.
100 g of genomic DNA is digested in aliquots (see above), 0.11 volume of 10 x STE and 0.3 volume of 1 x STE are added, and the mixtures are then extracted twice using 1 volume of phenol/chloroform/isoamyl alcohol (25:24:11, v/v/v). Precipitation takes place after addition of 0.5 volume of 7.5 M sodium acetate, 2 volumes of absolute ethanol, 30 minutes at -20 C. The DNA is washed with 70% ethanol, dried at room tempera-ture, and resuspended in 200 l of TE buffer while the pellets are combined. All centrifugation steps are carried out for 10 minutes at 12,000 g and 4 C. The digest is stored at -20 C.

10 x STE: 0.1 M NaCl, 10 mM Tris-HC1, pH 8, 1 mM Na2 EDTA

Klenow reaction 50 g of the partially digested genomic DNA in an overall volume of 350 l of 1 x fill-in buffer (1 x Klenow buffer: 50 mM Tris-HC1, pH 7.2, 10 MM MgSO4, 0.1 mM DTT, Promega; 0.166 mM dGTP, 0.166 mM dATP) with 15 U Klenow polymerase (5 U/ l, Stratagene). The reac-tion is stopped by adding 0.5 volume of STE buffer (0.1 M NaCl, 10 mM Tris-HC1, pH 8, 1 mM Na2 EDTA, pH 8), and the DNA is then treated with phenol and chloroform. After 0.5 volume of sodium acetate and 2 volumes of absolute ethanol have been added, the DNA
is precipitated for 30 minutes at -70 C, pelleted for 15 minutes at 12,000 g and 4 C and washed in 70%
ethanol. The dried pellet is resuspended in TE buffer and stored at -20 C.

Ligation into the Lambda Fix II/Xho I partial fill-in vector In a reaction volume of 10 l, 1 g of lambda DNA
(1 g/ l Lambda Fix II/Xho I partial fill-in vector) and 0.4 g of genomic DNA fragments in ligase buffer (10 mM Tris-HC1, pH 7.8, 10 mM MgCl2, 10 mM DTT, 1 mM
rATP, Promega) are resuspended on ice and incubated overnight at 6-8 C with addition of 3.75 U of T4 DNA
ligase (15 U/ l, Promega). To check the ligation effi-cacy, 0.3 g of the test insert (50 ng/ l, 12-kb pMF
test insert; BamH I fragment partially filled up with dATP, dGTP) is ligated with 1 g of lambda DNA under the abovementioned conditions as a control batch. The DNA is packaged the following day.
Packaging of the lambda DNA
To generate a representative genomic library, the total number of independent clones required is calculated using the formula described by Clarke and Carbon (1976). Aliquots of the ligation reaction are packaged, the titer is determined, and this result is used for calculating the number of independent clones per packaging reaction. If required, further packaging reactions are carried out. In total, the calculated minimum number of independent clones should be reached.
The Gigapack III Gold packaging extract by Stratagene was used to package the ligation products. A packaging extract (50 l) is partially defrosted by holding it in the hand, 1 l of ligation batch are added, and the mixture is stored on ice. To check the packaging efficacy, 0.2 g of lambda control DNA (wild type c1857 Sam7, 0.2 g/ l) are packaged in the same manner. The extract is carefully resuspended using a pipette and then incubated for 2 hours at room temperature. The reaction is stopped by adding 500 l of SM buffer (0.01% gelatin, 50 mM Tris-HC1, pH 7.5, 100 mM NaCl, 8 mM MgSO4) and 20 l of chloroform, and the solution is mixed by careful shaking. The mixture is then centrifuged for 1 minute at 16,000 g and 4 C. The supernatant is transferred into a reaction vessel and stored at 4 C until use. The titer plates are estab-lished the same day.
The following dilution levels of the individual packag-ing extracts are used:

Packaging extract Dilution level Ligation of B. vulgaris genomic DNA 1 x 101/1 x 10-1 Ligation of the control insert (pMF) 1 x 10-1/1 x 10-2 Control DNA (wild type c1857 Sam7) 1 x 10-3/1 x 10-4 Amplification of the genomic library To recover a highly concentrated phage suspension which can be stored at -80 C as a stable stock culture, the genomic library of B. vulgaris was amplified. The minimum number of independent clones required for the amplification should represent the entire genome (Clarke and Carbon, 1976).
Amplification takes place in the form of plate lysates (150 mm 0 LB agar plate). The amount of packaging extract required depends on the minimum number of independent clones (see above). 600 l of competent host cells per plating batch are infected with 50,000 pfu each and incubated for 15 minutes at 37 C
with gentle shaking. 6 ml of top agar is used for plating. The incubation time is approximately 8 hours at 37 C. Plaque size should reach a diameter of 1-2 mm.
The plates are then overlaid with 10 ml of SM buffer and incubated overnight in a refrigerated chamber on a tumble shaker at the lowest possible speed. The super-natants are transferred into a sealable centrifuge vessel, the plates are rinsed with 2 ml of SM buffer, and the supernatants are combined. After addition of chloroform (end concentration 5%), the phage suspension is incubated for 15 minutes at room temperature and separated from bacterial residues by centrifugation for 10 minutes at 2000 g. The supernatant is transferred into a sterile vessel, treated with chloroform (end concentration 3%), and can now be stored for several months at 4 C. After the titer of the amplified genomic library has been determined, aliquots are stored at -80 C in 7% DMSO (dimethyl sulfoxide) to provide a stock solution. The following dilution levels are employed for the titer determination (90 mm 0 LB
plates) : 1 x 10-6, 1 x 10-7, 1 x 10-1.

II. Methods for cloning promoter/reporter gene constructs for the V-ATPase promoters A, cl and c2, with the reporter genes luciferase (or P-glucuronidase) Subcloning genomic clones with promoter regions A single type of genomic clones was obtained for subunit A, while two different isoforms were isolated for subunit c clones. To subject the clone of the genomic subunit A to sequence analysis, a 4.3 kb EcoRI
fragment (pBVA/70) which hybridizes with subunit A cDNA
was subcloned into the vector pBluescript II SK+. For subunit c, an 8 kb XbaI/HindIII fragment (pBVA/16-1) and a 5 kb EcoRV/HindIII fragment were subcloned into the same vector.

Cloning of promoter/reporter gene constructs BVA/70 promoter A 1.3 kb HpaII fragment of the pBVA/70 clone was made blunt-ended using Klenow polymerase and ligated into the Smal site of the vector pBluescript in order to obtain pBVA/70. Restriction with Hindlll and BglII
resulted in a 1.3 kb promoter fragment with its 3' end in position -28 relative to the transcription start. To obtain the promoter-GUS fusion, the HindIII/BglII was ligated with the BamHI/EcoRI GUS cassette of pBI221 (Clontech) and then cloned into the vector pBluescript in order to obtain pBVA/70p-GUS. To obtain the promoter-LUC fusion, a PstI/BglII promoter fragment was ligated upstream of the BamHI/HindIII cassette of pCaMVLN and cloned into the vector pBluescript.

BVA/16-1 promoter The BamHI/EcoRI GUS cassette of plasmid pB1221 (Clontech) was cloned into pBluescript (pBGUS), from which it was excised using BamHI and Sall. A 1.3 kb PstI/BglII promoter fragment of pBVA/16-1 with its 3' end in position -40 relative to the transcription start was ligated with the GUS cassette and cloned into PstI/SalI-digested pBluescript in order to obtain pBVA/16-lp-GUS. The promoter-LUC fusion was cloned as described for BVA/70 (see above).
The plasmids pFF19G and pCaMVLN were used in each case as standards for GUS and LUC.

Characterization of the promoter/reporter gene constructs To compare the relative promoter activities of subunits A and cl of the Beta vulgaris V-type H+-ATPase, fragments of approximately 1.2 kb were isolated from the region upstream of the encoding region of the genomic clones pBVA-70 and pBVA-16/1. In this context, the term promoter characterizes the 5'-regulatory region and thus not only the promoter region, but also parts of the 5'-untranslated leader. These fragments were subsequently ligated into the phagemid vector pBluescript II SK+ upstream of the corresponding (see below) reporter gene cassettes. The reporter gene used was, in addition to (3-glucuronidase structural gene from Escherichia coli (uid A), the Photinus pyralis luciferase gene (Jefferson, 1987; de Wet et al., 1987).
The promoter/reporter gene constructs constitute "transcriptional fusions" since the 3' ends of the promoter fragments employed are in each case 30-4 bp upstream of the translation start of the genomic clones. Figure 1 is a schematic representation of the individual constructs. The expression vectors are here-inbelow termed pBVA-70(or 16)/GUS and pBVA-70(or 16)/LUC.

Characterization of the pBVA-70 promoter fragment The total size of this fragment is 1.237 kb. It encompasses the region between positions -1035 to +202 relative to the transcription start (+1) of the genomic clone pBVA-70, and thus contains, in addition to the promoter, most of the adjacent leader region (total length of leader = 230 bp).

Characterization of the pBVA-16/1 promoter fragment The total size of this fragment is 1.265 kb. It encompasses the region between positions -1130 to +135 relative to the transcription start (+1) of the genomic clone pBVA-16/1, and thus contains, in addition to the promoter sequence, most of the adjacent leader region (total length of leader = 174 bp).
Figure 1 is a schematic representation of the construct pBVA-70(16)/GUS and pBVA-70(16)/LUC. Fragments (approx.
1.25 kb) from the region of the 5'-untranslated region of the genomic clones pBVA-70 and pBVA-16/1 were ligated into the phagemid vector pBluescript II SK+
upstream of the respective reporter gene cassette. To prepare the promoter/GUS construct, the BamHI/EcoRI
cassette of vector pBI-221 by Clontech was used. In addition to the 3-glucuronidase structural gene from E. coli, it carries the polyadenylation region of the nopalin synthase gene (Ti plasmid, Agrobacterium tumefaciens). The promoter/LUC constructs were obtained using the BamHI/HindIII cassette of the vector pCaMVLN.
It contains the Photinus pyralis luciferase structural gene and the polyadenylation region of the nopalin sythase gene. The figures characterize the position of the cleavage sites of the promoter fragments used relative to the transcription start (+1) of the genomic clones.
Generation of a BVA/16-2 promoter/LUC construct A further reporter gene employed for preparing a construct was the Photinus pyralis luciferase gene (de Wet et al. 1987), EMBL Acc. No. M15077. To prepare a promoter/luciferase construct, the BamHi/Hindill cas-sette is excised from vector pCLN (pCaMVLN; Callis et al. 1987). It contains the Photinus pyralis luciferase structural gene (LUC) with the polyadenylation region of the nopalin synthase gene. This cassette is cloned into the vector pBluescript II SK (Stratagene) which has been cleaved with BamHi/Hindlll. The promoter/
leader fragment of the gene of subunit c (isoform 2) of the Beta vulgaris V-type H+-ATPase is excised from the construct pBVA/16-2 GUS (see above) using BamHI. The vector pBluescript II SK, into which the luciferase cassette has been cloned, is also opened up using BamHI, and the promoter with sticky ends thus cloned upstream of the luciferase. The position of the promoter fragment in the construct in the correct orientation (5'-3') upstream of the luciferase gene is checked by a variety of restriction digests (for example BamHI, SalI or XmnI). The transitions from the MCS of the vector to the promoter and from the other side of the MCS to the luciferase are checked by sequencing with the vector primers "M13 Forward" and "M 13 Reverse". The promoter/leader LUC construct is termed pBVA/16-2 LUC.

III. Methods for measuring the promoter activities in Beta cell cultures Ballistic transformation The ballistic transformation method (particle gum bombardment) was employed for the transient expression of promoter gene constructs in Beta vulgaris cell suspension cultures. This is a direct gene transfer method, whereby the DNA reaches the plant cell owing to the fact that the cell wall is destroyed mechanically (Sanford et al. (1987)).

A Biolistic PDS-1000/He particle delivery system, BIORAD was used.

During the experiment, the gas pressure in the pressure chamber rises and leads to the bursting disks being destroyed. The number of bursting disks used governs the pressure generated in the pressure chamber. As a consequence, the stream of helium gas escapes in a shocklike manner from the pressure chamber into the previously generated vacuum chamber. The escaping stream of gas accelerates the particle-coated macro-carrier, which is slowed down after only a few centimeters by means of a retaining net. The DNA-loaded microcarriers (here: tungsten particles), in contrast, pass through the interstices of the net and rupture the cell walls when they hit the plant material.

Microcarrier preparation In a reaction vessel, 1 ml of 70% ethanol is added to 30 mg of tungsten particles (microcarrier), and the mixture is vortexed for 20 seconds. A subsequent incubation for 10 minutes allows the particles to settle, and they are then sedimented for 30 seconds at 1300 g (unbraked) at room temperature. After the supernatant has been removed, the particles are washed with 500 ml of sterile double-distilled H2O as follows:
vortex for 10 seconds, leave to stand for 10 minutes, unbraked centrifugation for 30 seconds at 1300 g. The sedimented particles are then treated with 500 l of 50% glycerol and mixed by vortexing. They are stored at -20 C.

Loading of the microcarriers with DNA
The plasmid DNA required for the transformation should be free from impurities (protein, RNA) and should predominantly be present in supercoiled form. To isolate the DNA, commercially available plasmid kits are employed. To load the particles (microcarriers), it is recommended to assume a minimum number of 10-15 bombardments. The microcarriers rapidly settle out in the suspension during preparation, and small volumes make resuspending difficult. The volumes which follow are in each case per bombardment.
All steps with the exception of the centrifugation steps are carried out in a clean bench. The particle suspension is mixed thoroughly on a Vortex mixer, and 9- l-batches of the solution are subsequently trans-ferred into a reaction vessel. 1 l of plasmid DNA
(1 g/ l in TE buffer) is added with constant vortex-ing. The mixture is stored for 15 minutes in an ice bath. Then, 9 l of 2.5 M of CaCl2 (sterile), 3.6 l of 1.2 mM spermidine (filter-sterilized) and 18.2 l of absolute ethanol are subsequently added in succession, with gentle vortexing. After incubation for 10 minutes in an ice bath, the particles are sedimented for 5 seconds at 180 g at room temperature, and the super-natant is then removed. 6.4 l of absolute ethanol are added, and the particles are carefully resuspended by "finger vortexing" and stored in the ice bath until further use.
Preparation of the cell material For the gene transfer, the cell suspension culture used (here: 3-4 day-old Beta vulgaris culture) is trans-ferred to agar plates. To improve transformation efficiency, the osmotic value of the medium is increased by adding mannitol and sorbitol, and the cells are preincubated on this medium for approx.

4 hours. The effect of the osmotic treatment on the transformation efficiency of the plant cells can probably be attributed to the fact that plasmolysis occurs (Vain et al., 1993). It is possible that this prevents the cytoplasm from leaking out after the particle has entered the cell (Armaleo et al., 1990;
Sanford et al., 1992).
All steps, with the exception of the centrifuging steps, are carried out in the clean bench. To this end, 10 ml-disposable pipettes, tweezers, filter paper disks (45 mm 0), Buchner funnels and a wash flask are prepared. The materials with the exception of the disposable pipettes and the tweezers are autoclaved beforehand. Petri dishes (50 mm 0) provided with Gamborg B5 medium (0.9% agar supplemented with 0.5 g/l casein hydrolysate, 125 mm sorbitol, 125 mM mannitol, after Ingersoll et al. 1996) are also used.
The Buchner funnel is provided with a filter paper disk. Then, 3.3 ml of suspension culture, corresponding to approx. 1 ml of cell packed volume (see below) are distributed uniformly on the filter surface using a disposable pipette. The excess medium is removed via the wash flask by briefly applying a vacuum (approx.
2 seconds). The filter is transferred to a Petri dish containing nutrient medium, and the cells prepared in this way are stored in the clean bench at room temperature for 3-4 hours until the gene transfer takes place.

CPV determination At the beginning of the experiment, the cell packed volume (CPV) of the cell suspension culture is deter-mined. To this end, 10 ml of the suspension are removed under sterile conditions and sedimented for 5 minutes at 1130 g (swing-bucket rotor) in a 15 ml graduated centrifuge tube. The cell packed volume is determined with reference to the graduation.

Transformation All steps with the exception of the ultrasonic treat-ment of the particle suspension (see below) are carried out in the clean bench. Beforehand, the inside of the particle gun and all metal and plastic supports are cleaned with absolute ethanol. Equally, the retaining nets and the bursting disks are treated with ethanol and dried in the clean bench. The macrocarriers (M-20, BIORAD) are sterilized by briefly immersing them in absolute ethanol and transferring them into a desiccator.

The tungsten particle suspension is sonicated for 2 seconds at the maximum setting (Sonopuls HD 60, Bandelin), and 5- l-portions of the suspension (approx.
422 g particles, 0.78 g DNA) are carefully pipetted onto the macrocarrier surface. To prevent settling out, the particles are kept in solution between the pipetting steps by repeatedly finger-vortexing the reaction vessel. Then, a vacuum is applied to the desiccator for 20 minutes. Before the bombardment, the bursting disks (3 disks), the particle-loaded macro-carriers and the retaining net are fixed in accordance with the instructions. Position 3 is chosen for the Petri dish support charged with the suspension culture.
Then, the chamber is evacuated down to a vacuum of 27 inches (Hg), and the helium gas is passed into the pressure chamber. At a pressure of 1200 psi, the bursting disks rupture. The Petri dishes are then sealed under sterile conditions (Parafilm), and the cultures are incubated for 2 days at 24 C in permanent darkness.

Histochemical detection of 0-glucuronidase activity The transient expression of the P-glucuronidase struc-tural gene can be detected by a histochemical method.
To this end, after transformation has been carried out and an incubation time of 24 hours has elapsed, paper filters of suspension cultures are transferred into a Petri dish (50 mm 0) and overlaid with 1 ml of reaction buffer (see below). Incubation is carried out overnight at 37 C in an incubator. The number of zones which are stained blue is determined at 40 x magnification using a stereomicroscope.
To prepare the reaction buffer, 70 mg of X-Gluc (5-bromo-4-chloro-3-indolyl-p-D-glucuronic acid, Duchefa) are predissolved in 500 l of dimethyl sul-foxide and the solution is resuspended in 100 ml of a buffer solution (115 mM NaH2PO4 x 2 H20/Na2HPO4 x 2 H2O
pH 7, 10 mM Na2-EDTA, 0.5 mM K3 [Fe(CN)6], 0.5 mM K4 * Trademarks [Fe(CN)6]). Aliquots of the reaction buffer thus obtained can be stored over several weeks at -20 C.
Methods for quantifying the 0-glucuronidase and luciferase activities To quantify the enzyme activity of the reporter gene products used, detection methods were used which rely on bioluminescence and chemiluminescence. To determine the enzyme activity, the proteins are extracted before-hand. The "light quantity" generated in the subsequent enzymatic reactions is quantified in a luminescence spectrometer (Berthold, Lumat 9501). The measurement value obtained represents the light quantity integrated over a period of time. The measurement value is indicated as light units measured, "LU".

Preparation of the protein extracts The proteins are extracted using the "GUS-Light Assay"
(Tropix) and the "Luciferase Assay System" (Promega).
To prepare the protein extracts, the suspension cultures are removed from the paper filters using a spatula, the fresh weight is determined, and the cells are then disrupted using a pestle and mortar with addition of liquid nitrogen. Extraction buffer (500 gl/g FW) is pipetted to the frozen material, and the extract is defrosted and then thoroughly homogenized. Using cut-off pipette tips, the suspension is transferred into a reaction vessel on ice and centrifuged for 1 minute at 4 C and 16,000 g. The supernatants are kept on ice until the activity is determined.

Extraction buffer: ("GUS-Light Assay") The buffer solution (GUS lysis solution) is supplemen-ted with Q-mercaptoethanol prior to use (final concen-tration: 50 mm sodium phosphate buffer pH 7, 10 mM
Na2-EDTA, 0.1% SDS, 0.1% Triton* 10 mM (3-mercapto-ethanol). The solution is stored at room temperature until use.

* Trademark Extraction buffer: (Luciferase Assay System) The buffer (cell culture lysis reagent), which has a concentration of 5 x, is diluted with sterile double-distilled H2O at a ratio of 1:5 (final concentration:
25 mM Tris-HC1 pH 7.8 with H3PO4, 2 mM CDTA, 2 mM DTT, 10% glycerol, 1% Triton) and stored at room temperature until use.

Determination of (3-glucuronidase activity Detection reaction:
gusA gene - (3-glucuronidase 3-glucuronidase adamantyl-1,2-dioxethane-arylglucuronide methyl-3-oxybenzoic acid (glucurone) + light (470 nm) +
adamantyl group To detect the P-glucuronidase activity, the GUS-Light Kit (Tropix) was used. The manufacturer's instructions were followed for this.
Protein extract, reaction buffer and "accelerator" are pre-warmed to room temperature prior to use. After 20 l of protein extract have been transferred into a test tube (10 ml), the reactions are started by the staggered (20 seconds) addition of reaction buffer (in each case 180 l). The batches are incubated for 1 hour at room temperature in permanent darkness. Then, in each case 300 l of accelerator solution are pipetted to the reactions (staggered, see above). Immediately after the solution has been added, the individual samples are measured in a luminescence spectrometer (Lumat 9501, Berthold) with a delay of 5 seconds over a period of, again, 5 seconds.
Negative control The absolute values determined by the luminescence spectrometer cannot be attributed directly to the activity of a foreign gene. To determine the background value, which, in the case of 3-glucuronidase, may pos-sibly also be attributed to a comparable, endogenous activity, untransformed cell suspension cultures are studied by means of the above-described detection methods. The measurement values of this negative control (BW, blank value; see Tables la and lb) addi-tionally also contain the background values caused by buffer substances. To calculate the promoter activi-ties, the blank value is subtracted from the measure-ment values of the transformed culture.

Reaction buffer ("GUS Reaction Buffer") Prior to use, the substrate (glucurone, chemilumines-cent substrate) is diluted 1:100 in "GUS Reaction Buffer" (not complemented: 0.1 M sodium phosphate buffer, pH 7, 10 mM Na2-EDTA).

Luciferase activity determination Detection reaction:-luc gene - luciferase (Photinus pyralis) luciferase + Mg2+
ATP + Luciferin + 02 AMP + oxyluciferin + PPi +
light (560 nm) To determine the luciferase activity, the Luciferase Assay System (Promega) was used. The ratio of protein extract to reaction buffer was varied.
Both protein extract and reaction buffer (see below) are prewarmed to room temperature. After in each case 20 l (100 l) of protein extract have been transferred into a 10 ml test tube, 100 l (50 l) of reaction buffer are added to the sample and the batch is then measured immediately in the luminescence spectrometer (Lumat 9501, Berthold) over a period of 10 seconds.
According to what has been said for determining the (3-glucuronidase activity, a blank value is determined which is used for correcting the measurement values of transformed cultures.

Reaction buffer ("Luciferase Assay Reagent") To prepare the reaction buffer, the substrate (Luciferase Assay Substrate) is dissolved in the "Luciferase Assay Buffer" (final concentration: 470 M
luciferin, 270 M coenzyme A (lithium salt), 530 M
ATP, 20 mM trizin, 1.07 mM (MgCO3)4Mg(OH)2 x 5H20, 2.67 mM MgSO4, 0.1 mM Na2-EDTA, 33.3 mM DTT, pH 7.8).
The reaction buffer is divided into aliquots and stored at -70 C.

Determination of the relative promoter activity To quantify the promoter activity in promoter/ reporter gene constructs, the transient expression of the repor-ter genes is measured by means of the above-described enzymatic detection methods. However, when using direct gene transfer to determine promoter activity, the variation, between the individual transformations, of the measurement values obtained is frequently substan-tial. In the case of ballistic transformation, the efficiency of the gene transfer is affected on the one hand by the physiological state of the transformed tissue after the treatment. On the other hand, physical factors are also of importance, for example differences in the loading of the microcarriers or in the distribution of the particle suspension on the macrocarrier. The measurement values must therefore be supported by a calibration of the measurement system.
Theory of calibration Test plasmid Test promoter: To quantify the promoter activity, the transient expression of the reporter gene is determined by determining the enzymatic activity of its gene product. However, the promoter activity of the test promoter cannot be shown as an absolute value of the enzymatic activity determination. Quantification requires a comparison with the constitutive promoter (standard promoter).

Standard promoter: In a parallel set-up, the expression of the reporter gene under a constitute promoter (here:
CaMV 35S promoter) is studied. The promoter activity of the test promoter is indicated as the ratio activitytest promoter/ actiVitystandard promoter, the activity of the standard promoter equalling 1. Using expression of the reporter gene under a standard promoter as the reference base allows, inter alia, a comparison of the results from repeated experiments.

Calibration plasmid (internal standard) To record the transformation efficiency of individual bombardments (transformations), the microcarriers are loaded simultaneously with a test plasmid and a calibration plasmid. The constructs used (test plasmid, calibration plasmid) carry different reporter genes, thus allowing their expression data (enzyme activities) to be recorded in parallel.

The structural gene of the calibration plasmid is under the control of a constitutive promoter (here: CaMV
d35S, strength 35S promoter). The measurement values (enzyme activities) for the calibration plasmid reflect the transformation efficiencies of individual bombardments. All measurement values obtained for the internal standard (calibration plasmid) in one experiment are considered together and divided by the maximum value obtained in the experiment. Thus, the highest measurement value leads to a transformation efficiency of 1 (corresponds to 100%). The transformation efficiency (from 0-1) is indicated as relative light units "rLU". The absolute measurement values obtained in the study for the test plasmid (test promoter, standard promoter) are corrected taking into consideration the transformation efficiency of the bombardment. To this end, the activity determined for the test plasmid is divided by the transformation efficiency. The corrected values are termed relative activities. The ratio of test plasmid to calibration plasmid (7:3, w/w) is retained in all experiments.
Copy number Identical quantities of test plasmid DNA are employed in the transformation (here approx. 0.7 g per bombard-ment). When comparing the activities of test promoters and standard promoter (see above), plasmid size, i.e.
the number of molecules (copy factor) per pg of test plasmid DNA must be taken into consideration. The number of standard promoter molecules (test plasmid) employed per bombardment is taken as the reference value and made equal to 1. The measurement values for the activity of the test promoters are corrected taking into consideration the number of molecules (per bombardment).

Calculation of the relative promoter activity The example which follows shows an example of indi-vidual calculation steps to clarify this further.
The data refer to a study on the quantification of the relative promoter activity of the A-subunit promoter (70 kD) of the Beta vulgaris V-type H+-ATPase (test promoter, plasmid: pBVA-70/LUC). The CaMV 35S promoter (plasmid: PCaMVLN) was used as reference (standard promoter). Both test plasmids carry the luciferase structural gene (LUC). To record the transformation efficiency, the calibration plasmid pFF19G was used in the cotransformation. It carries the 3-glucuronidase structural gene (GUS) under the control of the enhanced 35S CaMV promoter.

The following combinations of test plasmid x calibra-tion plasmid were employed:

1. Test promoter: 70 kD UE-ATPase (pBVA-70/LUC) x CaMV d35S (pFF19G) 2. Standard promoter: CamV 35S (PcAMVLN) x CaMV d35S
(pFF19G) Plate LUC LUC GUS GUS Effi- Relative Mean acti- activity acti- activity ciency LUC
vity (-BV) vity (-BV) activity LU LU LU LU rLU rLU rLU
1 8070 7967 28734 22286 0.65 12257 2 10977 10874 40238 33790 0.99 10984 Table la: Calculation of the relative luciferase activity for the promoter construct of the 70 kD
subunit of Beta vulgaris V-type H+-ATPase (70 kD UE
ATPase/LUC x CaMV d35S/GUS) Background activity: The absolute values obtained from the determination of the enzyme activity (LUC and a-GUS
activity) of transformed cells were corrected by taking into consideration the measurement values of the nega-tive control (absolute value - blank value (BV)). The blank value for the LUC activity was 103 LU. The blank value for the GUS activity was 6448 LU. The LU (light units) indicated refer to the quantity of protein extract employed (here: 20 l). Transformation efficiency: the highest measurement value (GUS acti-vity) for the internal standard CaMV d35S/GUS, and thus the highest transformation efficiency, was obtained in plate 3. The values for the LUC activities of the remaining transformation batches were corrected by taking into consideration the respective transformation efficiency.

Plate LUC LUC GUS GUS Effi- Corrected Mean acti- activity acti- activity ciency LUC
vity (-BV) vity (-BV) activity LU LU LU LU rLU rLU rLU
1 4518 4415 13756 7308 0.21 21024 2 13572 13469 20566 14118 0.41 32851 13 11256 11153 17051 10603 0.31 35977 29951 Table lb: Calculation of the relative luciferase activity for the CaMV 35S promoter (35S CamV/LUC x CaMV
d35S/GUS); see legend to Table la To calculate the activity of the test promoter, the mean of the relative luciferase activity (see Table la) is corrected by taking into consideration the molecule number (copy factor) (see below). The relative strength of the test promoter is now expressed as the ratio between activity of the test promoter and activity of the standard promoter. In the present example, a value of 0.49 results for the relative promoter activity of the subunit A promoter of the Beta vulgaris V-type H-ATPase .

Promoter LUC Copy Corrected Promoter activity factor LUC activity strength (rLU) (rLU) 70 kD subunit 12324 1.2 14789 0.49 ATPase 35S CaMV 29951 1 29951 1 IV. Construction of the plasmid constructs for the ballistic transformation Figure 2 shows the construction of the construct pBVA-70/LUC. To obtain the luciferase construct pBVA-70/LUC, the 5'-regulatory region (1236 bp) of the gene for subunit A of the Beta vulgaris V-type H+-ATPase was liberated from plasmid pBVA-70 by means of a PstI/BglII digest. The genomic fragment was subse-quently cloned into the vector pBluescript SKII+
(Stratagene) upstream of the BamHI/HindIII cassette of vector pCaMVLN via the PstI/HindIII cleavage sites. The cassette contains the luciferase structural gene and also the polyadenylation region of nopalin synthase gene. Vector regions (U) are emphasized particularly in the BVA-70 promoter/LUC/CaMV/terminator cassette.
Figure 3 shows the construction of construct pBVA-16/LUC. To obtain the luciferase construct pBVA-16/LUC, the PstI/BglII fragment of the genomic subclone pBVA-16/1 (which was described in Figure 2) was cloned into the vector pBluescript II SK+
(Stratagene) upstream of the BamHi/Hindlil cassette of the vector pCaMVLN via the cleavage sites PstI/HindIII.
See legend to Figure 2.

V. Representation of the cloned 5'-deletions for the V-ATPase promoters A, cl and c2 Promoter deletions of the BVA/16-2 promoter/LUC
construct The starting construct for the promoter deletions is the promoter/leader luciferase construct pBVA/16-2 LUC.
This construct contains the overall promoter region with 1923 bp and additionally 87 bp of the leader (-1923 to +87 = 2010 bp). The ATPase promoter is to be deleted with the aid of the "Exo Mung Bean Deletion Kit" (Stratagene, 1997), starting from the 5'-end.
Figure 4 shows the BVA/16-2 promoter deletions. The top row of the figure shows the promoter region of the original genomic clone pBVA/16-2 with the leader up to the translation start (ATG). The transcription start is shown as +1. The individual deletion clones are shown schematically underneath, and the number of, the deletion clone is given. The number on the left-hand side shows the length of the remaining promoter, and the number on the right-hand side at the end of each row shows the total length of the deleted promoter and the leader portion (in each case +87 bp) in the promoter/ luciferase construct.

To prevent digestion of the vector, too, a restriction cleavage site for an enzyme in the MCS on the left of the vector is selected which cleaves neither in the promoter nor in the reporter gene. A restriction enzyme with a 3'-overhang requires no fill-in reaction. In the case of a restriction enzyme with a 5'-overhang, for example NotI, the sticky end is filled up after the digest with a-thio dNTPs with the aid of Klenow polymerase. First, the 5'-end of the promoter is shortened by 1121 bp with the aid of an Spel digest, starting at the 5-end. In the promoter/leader fragment of the construct, 812 bp of the promoter plus 87 bp of the leader = 889 bp remain. The Spel digest results in a 5'-restriction overhang. The enzyme exonuclease III
digests 5'-restriction overhangs which have not been filled up with a-thio-dNTPs. After the construct has been digested with NotI, subsequently filled up with a-thio-dNTPs and then digested with Spel, the 5'-deletion of the promoter with exonuclease III can be started (initially, 10 deletion points are chosen). The vector end of the construct remains unaltered. After the exonuclease III has been digested, the remaining overhangs are digested with mung bean nuclease. This gives rise to two smooth ends which can be ligated and subsequently transformed into E. coli competent cells.
After plasmid isolations and subsequent test digests with SacI/XbaI, the selected plasmids are subjected to incipient sequencing (TOPLAB) with the T3 vector primer (sense primer). Starting from the MCS on the left-hand side, the overhang of the vector pBluescript II SK into the 5'-deleted promoter is sequenced. Selected deletion zones are employed in the ballistic transformation using the particle gun: No. 4 with 600 bp promoter (687 bp promoter + leader), No. 9 with 541 bp promoter (628 bp promoter + leader), No. 17 with 364 bp promoter (451 bp promoter + leader), No. 20 with 294 bp promoter (381 bp promoter + leader), No. 19 with 223 bp promoter (310 bp promoter + leader) and No. 22 with 180 bp promoter (267 bp promoter + leader).

Promoter deletions of the BVA/16-1 promoter/LUC
construct In the subsequent studies, the promoter of isoform 2 of the subunit c of B. vulgaris V-type H-ATPase (BVA/16-2) will be compared with the promoter of the other isoform known to date (isoform 1 subunit c of Beta vulgaris V-type H+-ATPase, BVA/16-1). Thus, the promoter/leader luciferase construct pBVA/16-1 LUC
(Lehr et al. 1999) is also subjected to 5'-promoter deletions (see above). This promoter (BVA/16-1) was cloned into vector pBluescript II SK+ upstream of the BamHI/HindIII cassette of the vector pCLN (with the luciferase structural gene) as a PstI/BglII fragment.
The original construct contained the entire promoter region with 1126 bp and additional 131 bp of the leader (-1126 to +131 = 1257 bp). Finally, the deletion clones are also subjected to incipient sequencing. A clone in which deletions are carried out as far as into the leader is generated to act as a control for the promoter deletion clones. This clone therefore only contains 51 bp (+81 to +131) of the leader upstream of the luciferase. Initially, selected deletion clones are employed in the ballistic transformation with the particle gun: No. 164 with 863 bp promoter (994 bp promoter + leader), No. 1 with 662 bp promoter (793 bp promoter + leader), No. 34 with 361 bp promoter (492 bp promoter + leader), No. 55 with 110 bp promoter (241 bp promoter + leader) and the control No. 93 with 51 bp of the leader without promoter.

Figure 5 shows the BVA/16-1 promoter deletions. The top row shows the promoter region of the original genomic clone pBVA/16-1 with the leader up to the translation start (ATG). The transcription start is shown as +1.
The individual deletion clones are shown schematically underneath, and the number of the deletion clone is given. The number on the left-hand side shows the length of the remaining promoter, and the number on the right-hand side at the end of each row shows the total length of the deleted promoter and the leader portion (in each case +131 bp) in the promoter/ reporter gene construct.

Deletions for the V-ATPase A promoter The original construct pBVA/70-LUC contained 1035 bp 5'-upstream sequence based on the transcription start.
The following deletions were generated analogously to the procedure for cl and c2:

Deletion Position based on the transcription start d 15/47 -30 d 15/ -108 d 15/49 -164 d 13/4 -270 d 9/180 -356 s 6/80 -494 d 4/47 -591 d 4/46 -682 (=pBVA-70-LUC) Table 2: Deletion constructs of pBVA/70-LUC
VI. Comparison of the promoter activities of A, cl, c2 and CaMV35S under standard conditions Figure 6 shows the comparison of the activity of different promoters under control conditions. In this experiment with the transient gene expression by means of the ballistic transformation, the activities of the individual promoters are determined indirectly by the luciferase activity. The three V-type H-ATPase promoters BVA/16-1, BVA/16-2 and BVA/70 are compared with the CaMV 35S promoter. The end values of the luciferase activities are corrected with regard to each other by a cotransformation with the construct pFF19G.
The diagram shows the corrected end values with the standard deviations.
Luciferase activities:
corrected end values [RLU]
1. pBVA/16-1 LUC pFF19G (1:1) 561355 14.06 4.64 2. pBVA/16-2 LUC pFF19G (1:1) 120958 3.03 1 3. pCLN pFF19G (1:1) 39912 1 4. pBVA/70 LUC pFF19G (1:1) 134384 3.36 Table 3: End values together with promoter strengths (based on pCLN or 16-2) in this experiment under control conditions, the V-ATPase BVA/16-1 promoter is approximately 5 times more active than the BVA/16-2 promoter. The promoters BVA/16-2 and BVA/70 show comparable activities (the activity of BVA/70 is slightly greater than that of BVA/16-2). In comparison with the CaMV 35S promoter in the construct pCLN, the V-ATPase promoters BVA/16-2 and BVA/70 are approximately 3 times more active, and the strongest of these three ATPase promoters, BVA/16-1, shows an activity which is 14 times higher than that of pCLN.

Detection of the constitutive activity of the V-ATPase promoters for the isoforms cl and c2 in Beta vulgaris leaves The activities of the promoter/reporter gene constructs for c2 (full-length promoter) and cl (5'-deletion d164) were determined by particle bombardment on fully expanded leaves of plants which have been raised in the field. To this end, in each case 2 leaf disks (0 5 cm) one on top of the other in Petri dishes on moist paper filters were bombarded with the particle gun (1 bursting disk, 900 psi). Bombardment with 0.5 ug of plasmid (V-ATPase promoter/pFF19G=7.3). After the bombardment, the leaf disks were incubated for 24 hours in the light while floating on water in Petri dishes.
Promoter Experiment No. LUC activity CaMV 35S 1 2348 cl (d164) 565 c2 1691 Table 4: Detection of the constitutive activity of the V-ATPase promoters for the isoforms cl and c2 in Beta vulgaris leaves The results in Table 4 demonstrate that the promoters c2 and c1(d164) show activities which are comparable with CaMV 35S, even in fully expanded leaves. In parallel, a Northern blot analysis revealed that, as has already been shown for cl, the c2 isoform is also expressed constitutively in the root, in young leaves and in old leaves, as expected. As has already been described for ci (Lehr et al. 1999), salt stress of the plants results in an increased amount of transcript.
Northern blot analysis on the expression of the c2 isoform in Beta vulgaris Figure 7 shows a Northern blot analysis on the expression of the c2 isoform in Beta vulgaris. In each case, 10 Ng of total RNA were applied and hybridized with a gene-specific probe from the 3-UTR region. In each case two samples from control plants (left, center) and one sample from salt-treated plants (100 mM, 48 hours; right) were applied.

VII. Relative activities of 5'-deletions of the promoters A, cl and c2 in comparison to CaMV35S

Figure 8 shows the comparison of the activities of different deleted promoters under control conditions.
In this experiment with the transient gene expression by means of the ballistic transformation, the activities of the individual promoters are determined indirectly by the luciferase activity. The deleted V-type H+-ATPase promoters BVA/16-1 and BVA/16-2 are compared with the CaMV 35S promoter. The end values of the luciferase activities are corrected with regard to each other by a cotransformation with the construct pFF19G. The diagram shows the corrected end values with the standard deviations. The numbers beneath the columns refer to the various deletion fragments shown in Figures 4 and 5.

Promoter activities of various 5'-deletions of the V-ATPase A promoter in comparison to the CaMV 35S
promoter Promoter LUC activity CaMV 35S 48766 70-5LUC(-1035) 93459 (full-length promoter) d4/46 (-682) 90716 d4/47(-591) 89906 d6/80 (-494) 62572 d9/180(-356) 56545 d13/14(-270) 77619 d15/49(-164) 43623 d15/7(-108) 43046 d15/479(-30) 44448 Table 5: Comparison of the activities of various deleted promoters of the V-ATPase promoter of subunit A
under control conditions Table 5 shows the comparison of the activities of different deleted promoters of the V-ATPase promoter of subunit A under control conditions. In this experiment with the transient gene expression by means of the ballistic transformation, the activities of the individual promoters are determined indirectly by the luciferase activity. The deleted V-type H+-ATPase promoters of BVA/70 are compared with the CaMV 35S
promoter. The end values of the luciferase activities are corrected with regard to each other by a cotransformation with the construct pFF19G. The diagram shows the corrected end values. The numbers of the promoters indicate the various deletion fragments given in Table 3.

VIII. Promoter activities of various 5'-deletions of the V-ATPase cl promoter and of the CaMV 35S promoter during the grown of a Beta cell culture Table 6 shows the Promoter activities of various 5'-deletions of the V-ATPase cl promoter and of the CaMV
35S promoter during the grown of a Beta cell culture.
The activities were determined in Beta suspension cells 1.5, 3.5, 5.5 and 7.5 days after they were transferred to fresh medium.

Days after Promoter activities (LUC) transfer CaMV 35S d5/55(-110) d3/34(-361) dO/164(-863) 1.5 75141 51857 106816 165252 3.5 75170 59147 132474 219219 5.5 63916 44955 108072 157218 7.5 18192 16954 31877 51930 Table 6: Promoter activities of various 5'-deletions of the V-ATPase cl promoter and of the CaMV 35S promoter during the growth of a Beta cell culture IX. Effect of NaCl(KC1) stress on the promoter activities of A, cl, c2 and CaMV35S

Effect of NaCl (KC1 stress (125 mM/48 hours) on the activities of a 5'-deletion of the A promoter (d4/46 [-682bp]) and a 5'-deletion of the ci promoter (d164[-863]) in Beta cell cultures 1.5 days after the last transfer, the cells were suction-filtered on filter paper disks and incubated on Petri dishes with control medium or with addition of 125 mM NaCl (KC1). After the bombardment, they were incubated for a further 24 hours. Then, the LUC
activities were determined.

Promoter Control LUC activity +125 mM NaCl +125 mM KC1 CaMV35S 32527(100) 8384(26) 4711(14) d164(cl) 67841(100) 51380(76) 22379(33) CaMV35S 20924(100) 5036(24) n.d.
d4/46(A) 23165(100) 9886(43) n.d.
Table 7: Effect of NaCl or KC1 stress on the activities of the V-ATPase promoters The results demonstrate that the activities of the V-ATPase promoters are considerably less affected by NaCl or KC1 stress of the cells than the CaMV35S
promoter. Further information on this can be found in Lehr et al. (1999).
Figure 9 demonstrates that the comparable effect is also observed for the c2 promoter. The data shown are the activities after exposure to 125 mM NaCl for at least 24 hours. Also, Figure 9, at the bottom, shows in the Northern blot analysis that the transcript quantities for the V-APTase genes A, cl and c2 after exposure to salt are all elevated compared with the control treatment.

X. Effect of phosphate deficiency on the promoter activities of A, ci, c2 and CaMV35S

Effect of phosphate deficiency (48 hours) on the activities of a 5'-deletion of the A promoter (d4/46 [-682bp]) and a 5'-deletion of the ci promoter (d164 [-863]) in Beta cell cultures 1.5 days after the last transfer, the cells were suction-filtered onto filter paper disks and these were incubated on Petri dishes for 48 hours either in control medium or in phosphate-free medium. After the bombardment, they were incubated for a further 24 hours. Then, the LUC activities were determined.

LUC activity Promoter Control (+P) - Phosphate CaMV35S 33084(100) 6842(20) d164(cl) 97417(100) 32897(34) CaMV35S 20924(100) 2678(13) d4/46(A) 23165(100) 7406(32) Table 8: Effect of phosphate deficiency (48 hours) on the activities of a 5'-deletion of the A promoter (d4/46 [-682bp]) and a 5'-deletion of the ci promoter (d164 [-863]) in Beta cell cultures The results demonstrate that the activities of the V-ATPase promoters are markedly less affected by phosphate deficiency of the cells than the activity of the CaMV35S promoter.

XI. Effect of sucrose deficiency on the promoter activities of A, ci, c2 and CaMV35S
Effect of sucrose deficiency (48 hours) on the activities of a 5'-deletion of the A promoter (d4/46 [-682b ]) and a 5'-deletion of the ci promoter (d164 [-863]) in Beta cell cultures 1.5 days after the last transfer, the cells were suction-filtered onto filter paper disks and these were incubated on Petri dishes for 48 hours either in control medium or in sucrose-free medium. After the bombardment, they were incubated for a further 24 hours. Then, the LUC activities were determined.

LUC activity Promoter Control (+S) - Sucrose CaMV35S 33084(100) 31740(95) d164(cl) 97417(100) 71017(73) CaMV35S 20924(100) 6933(33) d4/46(A) 23165(100) 6780(29) Table 9: Effect of sucrose deficiency (48 hours) on the activities of a 5'-deletion of the A promoter (d4/46 [-682bp]) and a 5'-deletion of the cl promoter (d164 [-863]) in Beta cell cultures The results demonstrate that sucrose deficiency of cells affects the activities of the V-ATPase promoters to a similar extent as the activity of the CaMV35S
promoter.

XII. Coordinated wound induction of the V-ATPase genes A, c1, C2 and E in storage tissue of Beta beet Expression of V-ATPase and V-PPiase genes after wounding To detect the steady-state transcript levels of the V-PPiase and various V-ATPase subunits from the head, stalk and membrane-integral region, samples were taken at various points in time after wounding. After the RNA
was isolated, a Northern blot was carried out in which 15 pg of RNA were applied per point in time. The same blot was developed repeatedly in succession with different homologous biotin-labeled probes. To detect the transcripts of the two isoforms of proteolipid c, the gene-specific cl probe was stripped from the membrane after detection before hybridization with the gene-specific c2 probe took place. As can be seen from Figure 10, the cl probe was not stripped completely;
the bands of the slightly larger transcript of the isoform cl can still be recognized weakly above the signals of isoform c2, which, however, demonstrates that the mRNAs of the isoforms were indeed detected specifically. Since the transcripts of the A subunit and of the V-PPiase also migrate over a similar distance in the gel, the membrane was again stripped between the detection of the mRNA for the A subunit and for the V-PPiase.

The storage root of sugar beet is a tissue which requires a great deal of energy supply to the tonoplast in order to maintain its sucrose storage capacity.
Figure 10 shows that indeed both proton pumps in the vacuoles show a significant basal expression, as can be expected after staining with neutral red.

Figure 10 shows the Northern blot analysis for detecting the gene expression of V-ATPase and V-PPiase in storage parenchyma cells of sugar beet after mechanical wounding. In each case 15 pg of RNA were applied.
Wound-induced changes in V-ATPase at the protein level A Western blot analysis is chosen to test if the elevated transcription levels of a large number of V-ATPase genes which are observed after wounding in Northern blots are also reflected in elevated protein quantities. Membrane proteins and the enriched tonoplast fraction as well as the total microsome fraction, all of which had been isolated 0, 10 and 72 hours after wounding, were fractionated by electrophoresis in a 13% PAA gel and blotted onto a PVDF membrane. The membrane was subsequently developed with the antiserum against the K. daigremontiana V-ATPase holoenzyme. It emerged that no significant quantitative change in the V-ATPase subunits is observed in the total microsome fraction (Figure 11B).
In the enriched tonoplast fraction, too, the protein quantities of the subunits clearly remain constant after wounding, with one exception: subunit c, whose isoforms had also shown the strongest induction at the mRNA level, was markedly increased after wounding. This induction was equally strong in the enriched tonoplast fractions of two beets which were isolated independently of each other (Figure 11A).
Figure 11 shows the Western blot analysis with a polyclonal antiserum against the K. daigremontiana V-ATPase holoenzyme and shows wound-induced changes in V-ATPase on the tonoplast in the storage parenchyma of the sugar beet. A. After wounding, the subunit c protein quantity increases in the enriched tonoplast fraction as a function of time. B. In the total microsome fraction, the quantities of the individual subunits remain unchanged. In each case 5 pg of protein of the isolated membranes of two sugar beet were applied, beet 1: tracks 1, 3 and 5; beet 2: tracks 2, 4 and 6.

Reduced V-ATPase H+-pump activity after wounding As has been described in the above chapters, an induction at the mRNA level was found for several V-ATPase genes, and an elevated subunit c protein level on the tonoplast was found by Western blot analysis, after wounding. This gave rise to the question of whether these changes would also lead to an elevated proton pump performance of the V-ATPase. To study this, the H+-pump activity of isolated membrane vesicles of the microsomal and of the enriched tonoplast fraction in the presence of the inhibitors vanadate for P-ATPases and azide for F-ATPases was measured by means of the fluorescent dye acridine orange. Instead of sucrose, the pump medium contained 250 mM sorbitol to exclude effects caused by the H+ sucrose antiporter.

As shown in Figure 12, the H+-pump activity of the V-ATPase in the microsomal fractions is equally high before and after wounding. In contrast, 3 days after wounding, the proton pump activity in the enriched tonoplast fraction is increased by a factor of 3.3.

Accordingly, the protein levels of proteolipid c on the tonoplast (Figure 12), which are elevated after wounding, are accompanied by a significantly elevated H+-pump activity of the V-ATPase localized therein.
Figure 12 shows wound-induced changes in the H+-pump activity of the V-ATPase in the microsomal and in the enriched tonoplast fraction in the presence of 100 pM
vanadate and 1 mM azide. While the initial rate of the decrease in fluorescene ()F540) of acridine orange after addition of 1 mM MgATP to vesicles of the microsomal fraction (40 pg of protein) is equally high before and after wounding, the enriched tonoplast fraction (10 pg of protein) shows an increase by a factor of 3.3. The data shown are the means of in each case 3 individual measurements.

Claims (22)

WHAT IS CLAIMED IS:

1. A DNA construct with a plant B. vulgaris V-ATPase promoter subunit c isoform 2 [SEQ ID No.1] operatively linked with a heterologous gene.

2. The DNA construct as claimed in claim 1, wherein the nucleotide sequence of the plant B. vulgaris V-ATPase promoter subunit c isoform 2[SEQ ID No.1]
contains a deletion or wherein the promoter sequence is a hybrid of the B.
vulgaris V-ATPase promoter subunit c isoform 2 sequence [SEQ ID No.1], and wherein the promoter still has promoter activity.

3. The DNA construct as claimed in claim 1 or 2, which comprises a second promoter which can be regulated in a different manner than the first promoter, wherein said second promoter is a B. vulgaris V-ATPase promoter subunit A or subunit c isoform 1.

4. The DNA construct as claimed in any one of claims 1 to 3, wherein the heterologous gene is a selection marker or a resistance-mediating gene or a gene of other medicinal, agronomical or other interest.

5. A polynucleotide comprising the sequence of the promoter of B. vulgaris V-ATPase subunit c isoform 2[SEQ ID No.1].

6. The polynucleotide as claimed in claim 5, wherein its nucleotide sequence contains a deletion or wherein its nucleotide sequence is a hybrid of the sequence of the B. vulgaris V-ATPase subunit c isoform 2 promoter [SEQ ID No.1], and wherein the promoter still has promoter activity.

7. A recombinant vector which comprises a DNA construct as claimed in any one of claims 1 to 4.

8. The recombinant vector as claimed in claim 7, which is an expression vector.

9. A microorganism which is transformed with a recombinant vector as claimed in claim 7 or 8.

10. A transgenic plant cell or protoplast whose genome comprises a DNA
construct as claimed in any one of claims 1 to 4.

11. A method for the controlled expression of a heterologous gene in a plant cell or a protoplast, which comprises:
transforming the cell or the protoplast with a DNA construct as claimed in any one of claims 1 to 4 and subsequently exposing the transformed cell or the protoplast to such a biotic or abiotic stress that the expression of the heterologous gene which has been transformed by means of the DNA construct is controlled.

12. A method for the controlled expression of a heterologous gene in a plant, which comprises:
regenerating cells or protoplasts transformed with a DNA construct as claimed in any one of claims 1 to 4 to give rise to a transgenic plant and subsequently exposing the plant transformed in this way to such a biotic or abiotic stress that the expression of the heterologous gene which has been transformed by means of the DNA construct is controlled.

13. A method for producing a recombinant protein in a plant, which comprises:
transforming a plant cell or a protoplast with a DNA construct as claimed in any one of claims 1 to 4 and subsequently exposing the transformed cell or protoplast to such a biotic or abiotic stress that the recombinant protein transformed by means of the DNA construct is expressed.

14. A method of producing a recombinant protein in a plant, which comprises regenerating cells or protoplasts transformed with a DNA construct as claimed in any one of claims 1 to 4 to give rise to a transgenic plant and subsequently exposing the resulting transgenic plant to such a biotic or abiotic stress that the recombinant protein transformed by means of the DNA construct is expressed.

15. Use of a DNA construct as claimed in any one of claims 1 to 4 for producing a recombinant protein in a plant cell or a protoplast.

16. Use of a DNA construct as claimed in any one of claims 1 to 4 for producing a recombinant protein in a plant.

17. Use of a DNA construct as claimed in any one of claims 1 to 4 for expressing a gene in a plant under biotic or abiotic stress.

18. Use of a plant B. vulgaris V-ATPase promoter subunit c isoform 2 [SEQ ID
No.1] for expressing a gene in a plant under biotic or abiotic stress.

19. The use as claimed in claim 18, wherein the plant B. vulgaris V-ATPase promoter subunit c isoform 2[SEQ ID No. 1] contains a deletion or wherein the promoter sequence is a hybrid of the B. vulgaris V-ATPase promoter subunit c isoform 2 sequence [SEQ ID No.1], and wherein the promoter still has promoter activity.

20. The use as claimed in claim 18 or 19, wherein at least one further pyrimidine stretch is inserted into the plant promoter.

21. A plant cell or protoplast which is transformed with a DNA construct as claimed in any one of claims 1 to 4 and which is resistant to biotic or abiotic stress.

22. A plant cell or protoplast as claimed in claim 21, which is resistant to salt stress.